enVVeno Medical
NVNO | NASDAQ
$5.95
-$0.22 (-3.57%)
At close: Nov 16, 2026, 4:00 PM ET
$5.95
$0.00 (-0.08%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.57%
(1D)No price chart data available for 1D timeframe.
Rating
29.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #808/1021 (Top 79%)
Key Statistics
Market Data
Market Cap $4.13M
1D Range
5.80 6.44
52W Range
5.80 14.13
Valuation (TTM)
PE -0.02
PB 0.24
EV/EBITDA 0.89
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -324.6%
SBC Adj. FCF Yield -370.9%
SBC Impact -14.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 66.6% |
38.3%
FCF 3Y | 5Y 10.6% |
2.4%
Returns
ROA -79.8%
ROE -70.3%
ROIC -94.8%
Financial Health
Net Cash
$18.06M
Current Ratio 7.35
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer ad...
Sector Healthcare
Industry Medical - Devices
Employees 33
IPO Date May 31, 2018
Website www.envveno.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NVNO